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DOI 10.1016/j.chembiol.2011.10.017SUMMARY USPs are variable in both size and modular domain architec-Ubiquitin-specific proteases (USPs) are papain-like
isopeptidases with variable inter- and intramolecular
regulatory domains. To understand the effect of
these domains on USP activity, we have analyzed
the enzyme kinetics of 12 USPs in the presence and
absence of modulators using synthetic reagents.
This revealed variations of several orders of magni-
tude in both the catalytic turnover (kcat) and ubiquitin
(Ub) binding (KM) between USPs. Further activity
modulation by intramolecular domains affects both
the kcat and KM, whereas the intermolecular activa-
tors UAF1 and GMPS mainly increase the kcat.
Also, we provide the first comprehensive analysis
comparing Ub chain preference. USPs can hydrolyze
all linkages and show modest Ub-chain preferences,
although some show a lack of activity toward linear
di-Ub. This comprehensive kinetic analysis high-
lights the variability within the USP family.
INTRODUCTION
Since the 1980s, posttranslational modification of proteins by Ub
has been the focus of many studies due to the important role of
Ub in cellular processes (Hochstrasser, 2009; Pickart, 2004).
Ubiquitination canmediate amultitude of signals due to its ability
to form chains. It does so by using one of the seven lysine resi-
dues (K6, K11, K27, K29, K33, K48, and K63) or the N-terminal
amine (‘‘linear’’), with potentially a different signal for each
linkage. To counteract the effects of ubiquitination, the differen-
tial removal of Ub (chains) is carried out by deubiquitinating
enzymes (DUBs).
The human genome encodes nearly 100 putative DUBs
belonging to at least five subfamilies of isopeptidases (Nijman
et al., 2005). The ubiquitin-specific protease (USP) family is the
largest class of DUBs, with more than 60 members (Komander
et al., 2009a; Nijman et al., 2005). USPs are cysteine proteases
that use a papain-like mechanism to hydrolyze the isopeptide
bond between the carboxy terminus of Ub and the ε-amine of
the target lysine.1550 Chemistry & Biology 18, 1550–1561, December 23, 2011 ª2011ture, and these domains can include substrate-binding domains,
ubiquitin-like (UBL) domains, and other protein-protein interac-
tion domains (Nijman et al., 2005; Zhu et al., 2007) (Figure 1A).
They share a common papain-like fold, but the catalytic domains
can have large insertions (Ye et al., 2009), possibly directly
affecting activity, Ub binding, or localization as seen in USP4
(Luna-Vargas et al., 2011b), USP5 (Reyes-Turcu et al., 2008),
USP14 (Borodovsky et al., 2001), and CYLD (Komander et al.,
2008). In addition, some USPs need structural rearrangements
to bind their substrate and catalyze hydrolysis (Avvakumov
et al., 2006; Hu et al., 2002; Hu et al., 2005; Ko¨hler et al., 2010;
Samara et al., 2010).
USPs are often found in large protein complexes, and many
interaction partners of USPs have been identified (Sowa et al.,
2009). Although the function of most interaction partners is still
unclear, some play a role in the modulation of USP activity. For
example, GMP synthetase (GMPS) interacts and activates
USP7 (Faesen et al., 2011; Sarkari et al., 2009; van der Knaap
et al., 2005), whereas the WD40 repeat containing UAF1
(WDR48) activates USP1, USP12, and USP46 (Cohn et al.,
2007, 2009).
With its diversity of domain architectures, internal insertions
within the catalytic domain, and external modulators, the USP
family apparently requires different levels of regulation. This
poses a number of unanswered questions. For instance, what is
the variability of the activity between the catalytic domains and
the full-lengthproteins?Are therepreferences forUb-chain types,
and does this change in the presence of external modulators?
To address these questions, we have developed and
produced (El Oualid et al., 2010) chemical tools and used them
to characterize a set of 12 USPs. This revealed variations of
several orders of magnitude in catalytic turnover and Ub binding
and allowed characterization of intra- and intermolecular activity
modulation. We determined the chain preferences of all USPs
against all eight topoisomers. This showed modest chain spec-
ificity among the di-ubiquitin linkages that was variable between
USPs. We observe activity toward all topoisomers, except for
some USPs that are inactive toward linear di-ubiquitin. These
preferences did not change in the presence of the modulators.
Kinetic analysis of the hydrolysis showed that there is no addi-
tional Ub binding site, suggesting that the chain preferences
are achieved by steric hindrance or reduced catalytic turnover.Elsevier Ltd All rights reserved
Figure 1. Overview of the Characterized
USPs
(A) Domain architecture of the USPs used in this
study. The constructs used in this manuscript are
highlighted with corresponding residue numbers
and expression system.
(B) Final purification product of the USP constructs
shown on SDS-PAGE gel. An asterisk indicates
the expressed USP. USP7FL has an N-terminal
GST tag.
Related to Table S1.
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Biochemical Characterization of 12 USPsRESULTS
Protein Cloning, Expression, and Purification
Based on protein expression trials (Luna-Vargas et al., 2011a),
we identified constructs suitable for large-scale protein expres-
sion of 12 different USPs in either E. coli or Sf9 insect cells (Fig-
ure 1A). In this study, we could therefore include 16 constructs
containing either the (almost) full-length constructs (USP1DN,
USP7FL, USP11FL, USP12FL, USP16FL, USP25FL, and
USP46DN, with DN and DC denoting N- and C-terminal
truncations, respectively), or the catalytic domain (USP4CD,Chemistry & Biology 18, 1550–1561, December 23, 2011 ªUSP7CD,USP8CD,USP16CD,USP21CD,
USP30CD, and USP39CD) (Figures 1A
and 1B). In addition, we expressed and
purified two known USP activity modula-
tors: UAF1 (Cohn et al., 2007) and GMPS
(van der Knaap et al., 2005). Cloning, ex-
pression, and purification protocols are
provided in the Materials and Methods
section.
Large Variations in Both Catalytic
Turnover and Ub Binding
Although USP family members share
a homologous catalytic domain, many
contain insertions within their catalytic
domain or have additional domains with
the potential to influence their activity
(Luna-Vargas et al., 2011b; Ye et al.,
2009) (Figure 1A). To study these effects,
we determined the kinetic parameters of
all the USPs we have available. To this
end, we produced a minimal synthetic
Ub substrate fused at its C-terminus to
the small molecule 7-amino-4-methyl-
coumarin (UbAMC) (Dang et al., 1998; El
Oualid et al., 2010). The UbAMC
substrate is a reagent widely used to
assay DUB activity. Upon hydrolysis by
the DUB, the free AMC reporter molecule
produces a fluorescent signal that allows
for a direct read-out of activity (Figure S1A
available online). The presence of the
AMC moiety instead of the endogenous
target makes this into a minimal universal
substrate.This assay is performed in the presence of EDTA to prevent
inhibition by divalent cations (Ferna´ndez-Montalva´n et al.,
2007). Since this might affect the structural integrity of the
zinc-containing USPs (Figure 1), we also determined the relative
activity without EDTA (Figure S1B). The activity of all USPs
except USP30CD is unaffected. Here, the catalytic turnover is
decreased 2.5-fold upon addition of EDTA (Figure S1C). The
activity of USP30CD without EDTA is shown in Figure 2.
Overall, we observed variations of several orders of magnitude
in both KM and kcat between the USP constructs (Figure 2).
Previously published kinetic parameters of USPs are listed in2011 Elsevier Ltd All rights reserved 1551
Figure 2. Kinetic Parameters Using UbAMC
(A and B) Michaelis-Menten curves for the different USPs, obtained by determining the initial rates (V0) at different UbAMC concentrations, and for USPs with
intramolecular modulation (B). The assay was performed in duplicate.
(C) Overview of the kinetic parameters (kcat, KM, and kcat/KM) for the different USPs. Values for USP4 and USP7 are from Luna-Vargas et al. (2011b) and Faesen
et al. (2011), respectively.
(D) Activity classification of USPs, based on kinetic parameters, where group 1 represents the USPs with the lowest activity; group 2 contains USPs with
intermediate activity, and group 3 contains the USPs with the highest activity. Dashed lines link the catalytic domains with the corresponding full-length USPs.
Solid lines show the effect of intramolecular activating and inhibiting domains.
Related to Figure S1.
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Biochemical Characterization of 12 USPsTable S1. This substrate allows direct comparison of relative
activity among the USP family members. This resulted in a rough
classification in three groups based on the kinetic parameters
(Figure 2D). Group 1 represents the USPs whose activity is
very limited due to a low kcat (USP1DN, USP4CD, USP7CD,
USP12FL, USP39CD, and USP46DN). The ‘‘intermediate’’
group, group 2, contains the USPs that show moderate activity1552 Chemistry & Biology 18, 1550–1561, December 23, 2011 ª2011(USP4-D1D2, USP11FL, USP16CD, USP16FL, USP21CD,
USP25FL, and USP30CD), and group 3 contains very active
USPs (USP7FL, USP7CD-HUBL, and USP8CD).
As expected, group 1 contains USP39CD. It shows no activity,
since it lacks the catalytic cysteine and histidine residues (Nijman
et al., 2005). Group 1 also contains USP1DN, USP12FL, and
USP46DN, all three known to have low activity, which isElsevier Ltd All rights reserved
Figure 3. Di-Ub Topoisomer Preference for
the Different USPs
(A) Ub (1UBQ) Showing all Lysines.
(B) Overview of a time-course using all eight
different di-Ub topoisomers (5 mM) (Linear, K6,
K11, K27, K29, K33, K48, and K63) for the active
USPs (75 nM). Samples from each time point (0, 5,
10, 30, 60, and 180 min) were analyzed on
Coomassie-stained SDS-PAGE gels. The assay
was performed twice, and representative gels are
shown here.
Related to Figure S2.
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Biochemical Characterization of 12 USPsenhanced by the external modulator UAF1 (Cohn et al., 2009;
Cohn et al., 2007).
In contrast, group 3 represents the most active USPs, and
contains both USP8CD and the USP7 constructs with activating
C-terminal Hausp UBL (HUBL) domain (Faesen et al., 2011).
Interestingly, USP8CD has an unusually weak KM, possibly due
to an inserted a-helix in the catalytic domain, which is suggested
to stabilize the observed closed conformation (Avvakumov et al.,
2006). However, this is compensated by a very high catalytic
turnover, rendering it a very active USP overall.
Intramolecular Modulation of USP Activity
Not only do we observe differences in enzymatic behavior
between the USPs, but we also observe differential effects of in-
tramolecular domains on the activity of the (minimal) catalytic
domains in USP4, USP7, and USP16 (Figure 2B).
We recently showed that USP4 contains a UBL domain in-
serted in its catalytic domain (USP4CD; Figure 1A), which inhibits
the activity of USP4CD (group 1; Figures 2B and 2D) (Luna-Var-
gas et al., 2011b; Zhu et al., 2007). The presence of this UBL
domain in USP4CD increases the KM and is therefore less active
than the minimal catalytic domain USP4-D1D2 (group 2; Fig-
ure 2D) (Luna-Vargas et al., 2011b). In contrast, both kcat and
KM are affected in USP7, where the minimal catalytic domain
(group 1) shows far less activity than the full-length enzyme
(group 3). Here, the activity of USP7 is modulated by its HUBLChemistry & Biology 18, 1550–1561, December 23, 2011 ªdomain,which is essential for both activity
andUb binding in vitro and in vivo (Faesen
et al., 2011; Ferna´ndez-Montalva´n et al.,
2007; Ma et al., 2010). The activity of
USP16CD ismodulated by the zinc-finger
Ub specific protease (ZnF-UBP) domain.
Surprisingly, the activity is enhanced by
increasing catalytic turnover, rather than
by the KM (Figures 2B and 2D). Since it is
a Ub-binding domain, the effect of the
zinc-finger could be more prominent in
poly-Ub processing (Pai et al., 2007),
which might add up to a bigger difference
than observed here. USP39CD also
contains a Znf-UBP domain, but it is
unlikely that this will lead to enzymatic
activation since USP39CD does not
have the catalytic residues.Overall, this shows that several intramolecular domains are
able to modulate USPs. The modulation can affect KM (USP4),
kcat (USP16), or both (USP7), and both inhibitory and activating
domains are found in USPs. Together, this creates an additional
layer of regulation of the catalytic activity of USPs.
Di-Ub Preferences of USPs
Most studiesofDUBspecificity have focusedonprocessingK48-
and K63-linked poly-Ub. K48-linked ubiquitination targets
a protein for active degradation by the proteasome (Chau et al.,
1989),whereasubiquitin chainsusingK63havemostly nondegra-
dative outcomes (Chen and Sun, 2009). Our knowledge of func-
tionsof theother linkages is growing. For example, linear ubiquitin
chains play a role in the NFkB activation pathway and immune
response and are structurally similar to K63-linked poly-Ub (Ger-
lach et al., 2011; Komander et al., 2009b; Tokunaga et al., 2009).
K11 is also a strong degradation signal and is involved in the cell
cycle (Williamson et al., 2009). The roles of the other linkages
remain elusive, but they have been implicated in DNA damage
response (K6 by BRCA1/BARD1 (Wu-Baer et al., 2003)) or lyso-
somal degradation (K29 (Chastagner et al., 2006, 2008)).
Since the additional linkages serve important cellular func-
tions, we synthesized all seven lysine-linked di-Ub topoisomers
(El Oualid et al., 2010). Together with linear di-ubiquitin we used
them in a qualitative assay to assess all linkage preferences of
the panel of USPs (Figure 3 and Figure S2). Previously published2011 Elsevier Ltd All rights reserved 1553
Figure 4. Isopeptide-Linked Ubiquitin FP-
Reagents
(A) Schematic view of N-terminal TAMRA-labeled
Ub peptide (K6) conjugated with Ub. Table shows
the peptide sequences used with the corre-
sponding residue numbers for the different types
of Ub linkage. The conjugated lysine is highlighted.
(B) Michaelis-Menten curves for USP4-D1D2 (top)
and USP7FL (bottom) were obtained using the
TAMRA-labeled Ub peptides in an FP hydrolysis
assay. The curves for USP7 could not be fitted.
The assay was performed in triplicate.
Related to Figure S3.
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Overall, the relative activities from the UbAMC assay are re-
tained, with a few exceptions. For example, USP21CD shows
only intermediate activity in the UbAMC assay, but it displays
activities in the di-Ub assay almost matching the most active
USP, USP8CD.
The USP family seems to be rather promiscuous compared to
other DUB families. For example, the OTU family displays strong
linkage preferences for specific di-Ub topoisomers (Bremm
et al., 2010; Edelmann et al., 2009; Virdee et al., 2010; Wang
et al., 2009). Figure 3 shows that the differential activity of the
USPs is smaller. Most of the active USPs from this study hydro-
lyze all di-Ub topoisomers. Nevertheless, there are clear differ-
ences in efficiency. For instance, although USP1DN, USP7,
USP8CD, USP11FL, and USP25FL showed robust activity
toward the lysine-linked di-Ub topoisomers, we observe no
activity toward linear di-Ub. On the other hand, USP4, USP16FL,
and USP21CD are active against linear di-Ub. Of these three,
USP21CD is the only one that is less active against the linear
di-Ub compared to the other topoisomers. The hydrolysis of
linear di-Ub is unique for the USP family, since this feature is
not observed in other DUB families (Komander, 2010).
Also in the hydrolysis of the lysine-linked topoisomers we
observe differential activity. For instance, most USPs have diffi-
culties hydrolyzing K27- and, to a lesser extent, K29-linked di-
Ub. USP7 has limited activity toward hydrolyzing K27- and
K29-linked di-Ub. In contrast, the K6, K11, K48, and K63 Ub top-
oisomers are hydrolyzed relatively efficiently. Another clear
example is USP4, for which K63-linked di-Ub is a better
substrate than K48-linked di-Ub (Luna-Vargas et al., 2011b;
Song et al., 2010).
Wewonderedwhether the intramolecular modulating domains
in USP4, USP7, and USP16 change the linkage preferences. The
different USPs respond differently to modulation by internal
domains, analogous towhat was observed with UbAMC (Figures
3, S2B, and S2C). However, no change in linkage preferencewas1554 Chemistry & Biology 18, 1550–1561, December 23, 2011 ª2011 Elsevier Ltd All rights reseen between catalytic domain and
longer constructs, showing that the
modulation effects are substrate-inde-
pendent mechanisms.
Overall, this shows that in contrast to
other DUB families, USPs can hydrolyze
all di-Ub topoisomers, albeit with differ-
ences in catalytic efficiency. Also, someUSPs show perturbed activity toward linear-linked ubiquitin.
The differences in catalytic efficiency are preserved in the pres-
ence of the intramolecular activity modulators.
In the Case of USPs, Isopeptide-Linked Ub Is Not
Representative for di-Ub
To explain the Ub linkage preference, we might not need full-
length di-Ub (Shanmugham et al., 2010). To test this in an activity
assay, we designed and synthesized a panel of fluorescence
polarization-based (FP) reagents that mimic the lysine-linked
di-Ubs. In these reagents, TAMRA-labeled Ub peptides were
linked via an isopeptide linkage to the carboxy terminus of
wild-type full-length mono-Ub (Tirat et al., 2005) (Figures 4A
and S3)). Therefore, in contrast to the peptide linkage in UbAMC,
these FP reagents use the natural isopeptide linkage. The prox-
imal Ub is represented by 14-mer peptides, each representing
one of the seven lysines of Ub (Figures 3A and 4A). In addition,
a di-peptide (KG) was prepared to serve as a minimal substrate.
Mass spectrometry and SDS-PAGE analysis of these new Ub
substrates showed that the synthesis was successful for all eight
different TAMRA-labeled isopeptide-linked Ub FP reagents
(Figures S3C and S3F).
As a proof of principle, we used the minimal ‘‘KG’’ FP reagent
to determine the kinetic parameters of USP4-D1D2 (Figures 4B
and S4H). With this reagent we determined KM (293 nM) and
kcat (0.07 s
1) values similar to the kinetic parameters obtained
using UbAMC. Only the kcat is higher, possibly due to the differ-
ence in the chemical nature of the linkage, since the FP reagents
contain a natural isopeptide linkage in contrast to the UbAMC
reagent. However, since the KM values are similar, both repre-
sent comparable Ub reagents.
In the di-Ub time course assay, we observed linkage prefer-
ences of USP4-D1D2 and USP7; e.g., USP7 prefers the hydro-
lysis of K6- over K27-linked di-Ub, and USP4-D1D2 prefers
K63- over K48-linked di-Ub (Figure 3). Although difficult to fit
for USP7, with our FP reagents we observed no difference inserved
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Biochemical Characterization of 12 USPsactivity for either USP4-D1D2 or USP7 and therefore could not
recapitulate the preferences observed in the di-Ub assay
(Figures 4B, S3G, and S3H). This shows that these FP reagents
do not contain the information required to mimic di-Ub for USPs.
The Proximal Ub Hinders Binding to USP7 and USP21
in Specific Linkages
Since the FP reagents were not sufficient to reproduce the
observed linkage preference, we used full-length di-Ubs to
determine the kinetic parameters directly. We determined KM
and kcat of the hydrolysis of all di-Ubs by USP7 and USP21, using
gel-based initial rate experiments that monitored the appear-
ance of mono-Ub (Figure 5). These assays reproduced the differ-
ences observed in the time course assay (Figure 3). For USP7,
the kinetic parameters were similar to the UbAMC assay
(2.9 mM and 1.37 s1 in the UbAMC assay), but for USP21CD,
the kcat is 7- to 8-fold higher in the di-Ub assay (0.1 s
1 with
UbAMC). The KM is not tighter in the di-Ub assay compared to
the UbAMC (roughly 3 mM compared to 2.56 mM with UbAMC),
suggesting that there is no induced binding or catalysis effect
by the proximal Ub moiety.
These experiments showed that the linkages that are most
efficiently hydrolyzed by USP7 and USP21 (K6, K11, K33, K48,
and K63) have similar kinetic behavior (Figures 5B and 5C). In
the initial di-Ub assay, the K27, K29, and linear linkages showed
a clear delayed hydrolysis by USP7 and USP21 (Figure 3). This
was nicely reproduced in this kinetic di-Ub assay (Figures 5
and S4). Interestingly, for K27 and K29 for both USPs, there
was hardly any change in kcat; rather, the KM increased far above
the concentrations used in our assays. This suggests that the
preference for the di-Ub topoisomers arises from steric
hindrance rather than an additional binding site for the proximal
Ub moiety. Apparently, the binding of some linkages to the cata-
lytic domain is impaired, resulting in lower activity.
The linear di-Ub is a particularly bad substrate for USP7. Also,
in the kinetic analysis, no hydrolysis is observed, even when
using up to 15 mM of substrate (Figure 5A). On the other hand,
USP21CD is active toward linear di-Ub. The kinetic analysis
showed that both the kcat and the KM are reduced compared
to those of the other di-Ub topoisomers. This suggests
a decreased capacity to hydrolyze peptide bonds compared to
isopeptide bonds, with possibly a reduced binding as well.
Intermolecular Activation of USPs by UAF1 and GMPS
Only Affects kcat
Besides their intrinsic activity, some USPs are activated by inter-
molecular modulation. For example, USP1, USP12, and USP46
are activated by the WD40-repeat containing UAF1, and USP7
is activated by GMPS (Cohn et al., 2007, 2009; Faesen et al.,
2011; van der Knaap et al., 2005). Here, we used the UbAMC
assay to quantify this activation (Figures 6A, 6B, and S4). In
agreement with previous data, we observe mainly a kcat increase
(7-fold) of USP1DN activity in the presence of UAF1. The USP1
used in this work has a mutation in the self-cleavage site
(Gly671,672Ala) (Cohn et al., 2007). UAF1 also activates
USP12FL and USP46DN, where the kcat is increased by 66-
and 70-fold, respectively. Also, in the case of USP7, we
observed a kcat increase (5.5-fold) in the presence of its modu-
lator GMPS. Interestingly, in contrast to variable modulationChemistry & Biology 18, 1550–156invoked by internal domains (Figure 2D), intermolecular modula-
tion is achieved mainly by an increase in the catalytic turnover
rather than in substrate binding (Figure 6B).
To investigate whether this activation also induces new
linkage preferences of these USPs, we repeated the di-Ub assay
in the presence of UAF1 or GMPS (Figure 6C). As expected from
the UbAMC kinetics, USP1DN shows limited activity in the
absence of UAF1, andUSP12FL and USP46CD show no activity.
However, in the presence of UAF1, the activity of all three USPs
is increased, albeit not to the same level. In complex with their
activators, USP1DN and USP7CD-HUBL show themost activity,
but no change in chain-type preference by UAF1 or GMPS. This
agrees well with an activation mechanism that only increases
kcat, but does not induce binding, which should translate to
changing KM values.
DISCUSSION
In this study, we used novel reagents to determine the kinetic
parameters of substrate-independent activity of 12 USPs, their
di-Ub linkage preferences, and characteristics of both intra-
and intermolecular activity modulation. We observe large varia-
tions in both the catalytic turnover (kcat) and Ub binding (KM)
between USPs. This variability in activity can be explained in
several ways. First, the activity can be affected by structural re-
arrangements in both Ub binding sites and active sites, as shown
by structural studies (Avvakumov et al., 2006; Hu et al., 2002).
Second, intramolecular domains of USPs can modulate the
DUB activity, as seen here for USP4, USP7, and USP16. External
modulator proteins can further regulate the activity of the USP by
enhancing its activity, as seen for USP1, USP7, USP12, and
USP46 (Figure 6).
Here, we characterize a few cases where intramolecular
modulators regulate the USP catalytic efficiency: either inser-
tions within or additional domains outside the catalytic domain.
For both USP7 and USP16 the enzymatic behavior is regulated
by intramolecular domains (the HUBL and ZnF-UBP domains,
respectively) outside the catalytic domain, resulting in the
increase of the activity. In addition, variations in kinetics can be
induced by (large) insertions in the catalytic domains them-
selves, as demonstrated for USP4, where a UBL-containing
insert inhibits the catalytic efficiency (Luna-Vargas et al.,
2011b). These variations and intramolecular modulations result
in the unique activity of each USP.
For the last decade, the main focus on DUB specificity for Ub
chains has been on K48- and K63-linked poly-Ub chains.
However, different Ub linkage topoisomers can result in different
cellular fates, some of which are very specific (Jin et al., 2008;
Matsumoto et al., 2010; Wu et al., 2010) and require a minimal
chain length to invoke its function (Cook et al., 1994; Thrower
et al., 2000). Our study presents the first complete and compre-
hensive study on di-Ub preference of all eight linkages for USP
family members. Also, with our (mainly) synthetic di-Ub
substrate, we confirm earlier reports on preferences (Song
et al., 2010; Ye et al., 2011). Although none of the DUBs so far
has been tested for all Ub linkages, some DUBs show remark-
able specificity (Cooper et al., 2009; Edelmann et al., 2009; Kaya-
gaki et al., 2007; McCullough et al., 2004; Wang et al., 2009).
Next to CYLD (Komander et al., 2008), the USPs do not have1, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1555
Figure 5. Michaelis-Menten Kinetics of di-Ub Hydrolysis by USP7FL and USP21CD
(A and C) Representative western blots of theMichaelis-Menten analysis of di-Ub hydrolysis by USP7FL (A) and USP21CD (C). Assay was performed using 2-fold
dilutions of the di-Ub starting at 15 mM for 5 min at 37C.
(B and D) Michaelis-Menten analysis for USP7FL (B) and USP21CD (D) for di-ubiquitin hydrolysis. Initial rate (V0) of di-Ub conversion into mono-Ub was
determined at different substrate concentration from western blots shown in (A). The conversion to mono-Ub was quantified using the unsaturated di-Ub signal
corrected for conversion. The assay was perfomed in duplicate.
Chemistry & Biology
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Figure 6. Intermolecular USP Activity Modulation Is Achieved by Increasing kcat
(A) Kinetic parameters (kcat, KM, and kcat/KM) using UbAMC as the substrate for USP1DN, USP12FL, and USP46DN in the presence of UAF1 and USP7CD-HUBL
in the presence of GMPS. The assay was performed in duplicate.
(B) Graphical comparison of the kinetic parameters comparing the USP activity between the USPs and in the presence of their modulator.
(C) Activity modulation by UAF1 and GMPS toward all eight di-Ub topoisomers. The USP concentration used was 75 nM. Samples from each time point (0, 5, 10,
30, 60, and 180 min) were analyzed on Coomassie-stained SDS-PAGE gels.
Related to Figure S4.
Chemistry & Biology
Biochemical Characterization of 12 USPsstrict chain-type specificity, but rather have preferences. Kinetic
analysis of the hydrolysis by USP7 and USP21 showed us that
there is no proximal S10 Ub binding site to induce Ub topoisomer
preference; rather, the proximal Ub moiety induces steric
constraints for binding to the USP in the case of K27 or K29 link-
ages. These linkage preferences might be increased when using
longer Ub chains, since some might be ordered in higher-order
structures (Bremm et al., 2010; Tenno et al., 2004; Varadan
et al., 2002).
Overall, the hydrolysis efficiency of the USPs toward K6-,
K11-, K48-, and K63-linked Ub was higher than for K27- and,
to a lesser extent, K29- and K33-linked di-Ub. These residues
localize in distinct regions on Ub (Figure 3A). The lysine residues
involved in the most easily hydrolyzed linkages (K6, K11, K48,
and K63) are in the b-sheet or loops. In contrast, the lysine resi-
dues of the more difficult linkages (K27, K29, and K33) are posi-
tioned on the other side of the Ub molecule, and are all in the
a1-helix. In addition, K27 is barely accessible, which possibly
induces a steric constraint, resulting in the lower activity. This
interesting property needs future investigation.
Compared to the other DUB families, the USPs display a more
promiscuous behavior and some are able to hydrolyze all Ub
topoisomers with modest differences. For some USPs, the
activity toward linear di-Ub is slower or even completely lost
(Figures 3B and 5A). There are several possible explanations.
First, there is a difference in chemistry due to the lower pKa of
the N-terminal amine (9.2) compared to the ε-amine of lysineChemistry & Biology 18, 1550–156(10.5). Second, the peptide bond in linear di-Ub is conformation-
ally more restrained compared to the more flexible isopeptide
lysine linkage. Finally, the large side chain of the N-terminal
methionine introduces steric hindrance in the (‘‘linear’’) peptide
bond. Any of these aspects could influence binding and/or cata-
lytic efficiency of the hydrolysis of the peptide bond. Still, DUBs
from the other families are not able to hydrolyze linear-linked Ub
chains, and therefore the USP family is the only known family
with members that can process this linkage type.
A previous study suggested that Ub-peptide reagents might
be sufficient to discriminate between topoisomers in binding
(Shanmugham et al., 2010). However, in our activity assays
with the FP Ub-peptide reagents, we observed no difference
between Ub linkages. This suggests that the peptides do not
contain enough information to mimic the proximal Ub for the
USPs. Nevertheless, they may be sufficient for DUBs from fami-
lies with more pronounced Ub specificity and be useful tools in
those cases.
In our di-Ub assays, some USPs seemed more active
compared to the UbAMC assay. For example, USP7 was one
of the most active substrates in the UbAMC assay, whereas in
the di-Ub assay, this activity was matched by USP11 and
USP16. In our kinetic analysis of the di-Ub hydrolysis, we
observe no changes in catalytic parameters for USP7, which
shows that this enzyme does not differentiate between the two
substrates. This subsequently shows that several other USPs
are more active against di-Ub, which is an endogenous1, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1557
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could prove a good alternative for UbAMC, since it contains
the natural isopeptide linkage, which is not present in UbAMC.
Using the KG FP reagent with USP4-D1D2 and USP21CD shows
a slightly higher kcat compared to UbAMC (Figures 4B and S3I).
Therefore, this suggests that for some USPs the KG FP reagent
may be a better substrate, and provide more relevant kinetic
parameters.
This study confirmed that the modulator UAF1 activates
USP1, USP12, and USP46, and GMPS activates USP7. This
activation occursmainly by increasing the kcat. However, the bio-
logical roles of the UAF1 and GMPS activation are distinct. UAF1
activation is almost essential for USP activity of USP1, USP12,
andUSP46. This resembles theUbp8 activation by Sgf11 (Ko¨hler
et al., 2010; Samara et al., 2010). Surprisingly, USP12 in complex
with UAF1 is still not very active, possibly requiring additional
partners, like WDR20 (Kee et al., 2010). In a different manner,
GMPS hyperactivates USP7, by allosterically stabilizing the
active state of the enzyme induced by the HUBL domain (Faesen
et al., 2011). Besides this general activation, the GMPS activity
modulation most likely has additional substrate-specific roles,
as it induces histone H2B deubiquitination (van der Knaap
et al., 2005).
Although the functions of an increasing number of USPs have
been elucidated, they still represent a relatively uncharacterized
enzyme family. To aid in the biochemical understanding of these
enzymes, we here report large variations in kinetics and intramo-
lecular modulation (kcat and KM) and a characterization of the
activation by intermolecular interactions (kcat). Although some
USPs show a lack of activity toward linear di-Ub, it is the only
DUB family with members that can hydrolyze all topoisomers
with a modest but surprising differential activity. The combined
data provide insights in the variation in the biochemical behavior
of the USP enzyme family.
SIGNIFICANCE
Ubiquitination is a dynamic process that is involved in
numerous key cellular processes. The removal of the Ub
molecules is an integral part of this process and is carried
out by deubiquitinating enzymes (DUBs). These are increas-
ingly recognized as interesting drug targets. However, to
date, we lack the markers to predict the biochemical
behavior based on sequence alignments, and therefore,
a need exists for comprehensive kinetic studies. This is
where chemical tools that allow fast and accurate read-
outs will contribute to answering these biological questions.
In this study, we designed and produced several such chem-
ical reagents to determine the kinetics and di-Ub linkage
preferences of 12 USPs. Despite the homologous catalytic
domain, the kinetic data underline the large variability within
the USP family, and the intra- and intermolecular activity
modulators create an additional layer of regulation.
In addition, this study for the first time reports the linkage
preference of 12 USPs against all possible di-Ubs. This
family represents the first DUB family that can hydrolyze
all di-Ub topoisomers, albeit with small differential activity.
Kinetic analysis of the hydrolysis of the di-Ub topoisomers
suggests that within the USP family some of the preferences1558 Chemistry & Biology 18, 1550–1561, December 23, 2011 ª2011are induced by steric hindrance rather than induced binding,
as seen in other DUB families.
Together, these data provide insight into the biochemical
behavior in the USP family and validate the chemical tools




General reagents were obtained from Sigma Aldrich, Fluka, and Acros
and used as received. Solvents were purchased from Biosolve or Aldrich.
Peptide synthesis reagents were purchased from Novabiochem. cDNA of
USP1, USP12, USP46, and UAF1 were obtained from Martin A. Cohn and
Alan D’Andrea, USP4 and USP8 from Annette Dirac and Rene Bernards,
USP21 and USP39 from Elisabetta Citterio, USP30 from Carlos Lopex-Otin,
and USP25 from Erik Meulmeester and Frauke Melchior. Linear di-Ub was
purchased from Boston Biochem.
General Plasmids and Proteins
Di-Ub moieties were produced as previously described (El Oualid et al., 2010).
USP4CD (aa 296–954), USP4-D1D2 (aa 296–490/766–932), USP8CD (aa 776–
1110), USP11FL (aa 1–920), USP16FL (aa 1–823), USP16CD (aa 193–823),
USP21CD (aa 211–565), USP30CD (aa 65–500), USP39CD (aa 222–565),
andUSP46DN (aa 8–366) are cloned into the pETNKI-LIC vector for expression
in bacteria as described (Luna-Vargas et al., 2011a). USP1DN (aa 21–785 self-
cleavage site glycine 671 and 672 are mutated to alanine), USP7FL (aa 1–
1102), USP12FL (aa 1–355) and STREP-TEV-UAF1 (aa 6–677) are cloned
into the pFastBac-HTb vector for expression in insect cells. Both USP7CD-
HUBL (aa 208–1102) and USP7CD (aa 208–560) are cloned into the pGEX
vector (Faesen et al., 2011), and USP25FL is cloned in the pET11a vector
(Meulmeester et al., 2008). Codon-optimized full-length USP7 and GMPS
cDNA was obtained from DomainEx (Cambridge, UK). Genes USP7 and
GMPS were both PCR-amplified and subcloned (SpeI/NotI) into a pFastBac
vector (Invitrogen) containing an N-terminal GST tag (BamHI/SpeI) and Presci-
ssion Protease cleavage site. cDNA for USP11 and USP16 was obtained from
ImaGenes (Berlin, Germany).
Protein Expression and Purification
As specified in Figure 1, the USPs were expressed in both E. coli and insect
cells and purified as described (Faesen et al., 2011; Luna-Vargas et al.,
2011a). GMPS was expressed and purified as before (Faesen et al., 2011). De-
pending on the type of vector, the tag was removed with either TEV or the HRV
3C protease. Bacmids were prepared following the manufacturer’s guidelines.
USP1, USP12, and UAF1 were produced using Sf9 and Sf21 insect cell
expression. Infection was done using a low-MOI infection protocol (Fitzgerald
et al., 2006). The cells were harvested 72 hr after a baculovirus-induced growth
arrest was observed. USP46 was produced in E. coli. USP1, USP12, USP46,
and UAF1 were purified using Ni2+ sepharose (GE Healthcare, Waukesha, WI)
in 20 mM HEPES (pH 7.5), 150 mM NaCl, 0.1 mM PMSF, and 0.1 mM DTT fol-
lowed by elution using imidazole. His-tag was removed by overnight cleavage
with TEV protease while dialyzing to remove imidazole. Uncleaved product
was removed with Ni2+ sepharose. Size exclusion chromatography was per-
formed using a Superdex 200 or 75 column (GE Healthcare), equilibrated
against buffer containing 10 mM HEPES (pH 7.5) 100 mM NaCl, and 1 mM
DTT. All proteins were concentrated to 10 mg/ml and stored at 80C.
UbAMC Assay
Kinetics was determined as described before (Luna-Vargas et al., 2011b). The
activity was assayed at 25C in 50 mM HEPES buffer (pH 7.5), 100mM NaCl,
1 mM EDTA, 5 mM DTT, and 0.05% (w/v) Tween-20. Assays were performed
in nonbinding surface, flat-bottom, low-flange black 384-well plates (Corning)
in a 30 ml reaction volume. Fluorescence was measured at 5-min intervals
using a Fluostar Optima plate reader (BMG Labtechnologies, de Meern, The
Netherlands) at excitation and emission wavelengths of 355 nm and 460 nm,
respectively. All replicate assayswere performed simultaneously in duplicates.
USP concentration varied between 1 and 100 nM, depending on relativeElsevier Ltd All rights reserved
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ground signal (no enzyme). UAF1 and GMPS were added in a 1:1 stoichiom-
etry. USPs were added immediately before the first measurement. In order
to calculate the kinetic parameters for the hydrolysis of UbAMC, curves
were obtained by plotting the measured enzyme initial rates (v) versus the cor-
responding substrate concentrations ([S]). These were subjected to nonlinear
regression fit using the Michaelis-Menten equation V = (Vmax3 [S])/([S] + KM)
(Equation 1), where Vmax is the maximal velocity at saturating substrate
concentrations and KM the Michaelis constant. The kcat value was derived
from the equation kcat = Vmax/[Eo] (Equation 2), where [Eo] is the total enzyme
concentration. Experimental data were processed using Prism 5.01 (Graph-
Pad Software).
Di-Ub Assay
Di-Ub hydrolysis reactions were performed at 37C in 50 mM HEPES buffer at
pH 7.5, with 100 mM NaCl, 1 mM EDTA, 5 mM dithiothreitol, and 0.05% (w/v)
Tween-20with constant enzyme concentration (75 nM).When indicated, UAF1
was added in a 2-fold excess (150 nM) and GMPS in a 1:1 stoichiometry.
Experiments were performed using several preps of the di-Ub topoisomers,
some containing small amounts (<5%) of mono-Ub. The kinetics assays
were performed using the cleanest samples. Reactions were stopped by addi-
tion of SDS loading buffer and followed by SDS-PAGE analysis. The time
course assay (Figure 3) has been repeated at least two times. For the kinetic
analysis, the reaction mixture was preheated to 37C degrees before adding
USP7. Samples were run on a 12% Bis-Tris NuPage gel (duplicates on one
gel), and western blots were performed with anti-Ub antibody (Santa Cruz,
CA; P4D1). The ChemiDoc system (Biorad) was used to read the chemilumi-
nence signal. Quantification of mono-Ub was done using the quantification
tools of ImageLab (Biorad) using a marker of known amount of mono-Ub
and the non-saturated di-Ub signal (including a correction for the amount of
di-Ub converted to mono-Ub). Experimental data were processed using Prism
5.01 (GraphPad Software).
Solid-Phase Peptide Synthesis of the TAMRA Thiolysine Peptides
Solid-phase peptide synthesis (SPPS) of the TAMRA thiolysine peptides was
performed on a Syro II MultiSyntech Automated Peptide synthesizer using
standard 9-fluorenylmethoxycarbonyl (Fmoc)-based solid-phase peptide
chemistry at 25 mmol scale, using fourfold excessof amino acids relative to pre-
loaded Fmoc amino acid Wang type resin (0.2 mmol/g, Applied Biosystems).
The following protected amino acids were used during Ub peptide synthesis:
Fmoc-L-Ala-OH, Fmoc-L-Arg- (Pbf)-OH, Fmoc-L-Asn (Trt)-OH, Fmoc-L-Asp
(OtBu)-OH, Fmoc-L-Gln (Trt)-OH, Fmoc-L-Glu (OtBu)-OH, Fmoc-Gly-OH,
Fmoc-L-His (Trt)-OH, Fmoc-L-Ile-OH, Fmoc-L-Leu-OH, Fmoc-L-Lys (Boc)-
OH, Fmoc-L-Met-OH; Fmoc-L-Phe-OH; Fmoc-L-Pro-OH; Fmoc-L-Ser (tBu)-
OH; Fmoc-L-Thr (tBu)-OH, Fmoc-L-Tyr (tBu)-OH, and Fmoc-L-Val-OH.
Fmoc-5S-(methyldisulfanyl)-(L)-Lys (Boc)-OH was synthesized as described
previously (El Oualid et al., 2010).
The coupling procedure starts off with single couplings in N-methylpyrroli-
don (NMP) for 45 min using PyBOP (4 equiv) and DiPEA (12 equiv) in a total
volume of 750 ml. This is followed by removal of Fmoc with 20% piperidine
in NMP for 2 3 2 and 1 3 5 min. The procedure ends with NMP wash steps
after each coupling (3 times) and deprotection (5 times).
The resin was washed with diethylether and dried under high vacuum. Next,
the polypeptide sequence was detached from the resin and deprotected by
treatment with TFA/H2O/Phenol/iPr3SiH 90.5:5:2.5:2 v/v/v/v for 2.5 hr. After
washing the resin with 3 3 1 ml TFA, the crude protein was precipitated with
cold Et2O/n-pentane 3:1 v/v. The precipitated protein was washed 3 times
with diethylether; the pellet was dissolved in a mixture of H2O/CH3CN/HOAc
(65:25:10 v/v/v) and finally lyophilized. All peptides were analyzed by LC-MS
and purified by RP-HPLC when necessary.
LC-MS
LC-MS measurements on the FP reagents or components thereof were per-
formed on a Waters (Milford, MA) 2795 Separation Module (Alliance HT),
equipped with a Waters 2996 Photodiode Array Detector (190-750nm), Phe-
nomenex Kinetex C18 column (2.1 3 50, 2.6 mm), and LCT orthogonal accel-
eration time-of-flight mass spectrometer. Samples were run using two mobile
phases: A, 0.1% formic acid in water; and B, 0.1% formic acid in acetonitrile.Chemistry & Biology 18, 1550–156Flow rate, 0.8 ml/min; runtime, 6 min; column T, 40C. Gradient: 0–0.5 min, 5%
B; 0.5–4 min: 5%–95% B; 4–5.5 min, 95% B. Data processing was performed
using Waters MassLynx Mass Spectrometry Software 4.1 (deconvolution with
Maxent1 function).Ligation of Ub to the Peptides Followed by Desulphurization
Schematic overview of reaction scheme to create final FP reagents and the
corresponding final yields can be found in Figure S3. A mixture of 4-mercap-
tophenylacetic acid (MPAA, 100 mM) and TCEP (50 mM) in 6 M guanidi-
nium$HCl (1 ml, pH 7) was added to Ub-MesNa thioester (5 mg, prepared ac-
cording to the procedure described previously (El Oualid et al., 2010). To this
the TAMRA thiolysine peptide (100 ml of a 20 mM stock solution in DMSO) was
added and the whole mixture was incubated at 37C. After overnight incuba-
tion, all low-molecular-weight material was removed using a 3-kDa cutoff spin-
column (Amicon Ultra) in four centrifuge cycles. The crude material was taken
up in 6 M guanidinium$HCl and 0.1 M sodium phosphate (4 ml, pH 6.5), and to
this was added TCEP (187 mg) and glutathione (30 mg), after which the pH of
the mixture was adjusted to pH 6.5 by addition of 1 M NaOH. Next, the mixture
was degassed with argon, after which radical initiator VA-044 was added. The
mixture was incubated at 37C overnight. All constructs were purified by RP-
HPLC and analyzed by LC-MS and gel electrophoresis and were obtained as
purple solids.C18 RP-HPLC
Purification of the FP reagents by RP-HPLC was performed on a Shimadzu
system equipped with an LC-20AT liquid chromatography pump, CTO-20A
column oven (T = 40C), SPD-20A UV/VIS detector (detection simultaneously
at 230 nm and 254 nm), RF-10AXL fluorescence detector (ex/em = 540/
600 nm), and Atlantis Prep T3 column (10 3 150 mm, 5 mm). Samples were
run using two mobile phases: A, 0.05% trifluoroacetic acid in water; and B,
0.05% trifluoroacetic acid in acetonitrile. Flow rate, 7.5 ml/min; runtime,
30 min. Gradient: 0–6 min: 5%–10% B; 6.5–26 min: 25%–47% B; 26.5–
29.5 min: 95% B. Pure fractions were pooled and lyophilized.Isopeptide-Linked Ub FP Hydrolysis Assay
FP assays were performed on a PerkinElmer Wallac EnVision 2010 Multilabel
Reader with a 531 nm excitation filter and two 579 nm emission filters. The
confocal optics were adjusted with TAMRA-KG (synthesized by SPPS as
described above) and the G factor was determined using a polarization value
for TAMRA-KG (25 nM) of 50 mP. The assays were performed in nonbinding-
surface, flat-bottom, low-flange black 384-well plates (Corning) at room
temperature in a buffer containing 20 mM Tris$HCl, pH 7.5, 5 mM DTT,
100 mM NaCl, 1 mg/ml 3-[(3-cholamidopropyl) dimethylammonio] propane-
sulfonic acid (CHAPS), and 0.5 mg/ml bovine gamma globulin (BGG). Each
well had a volume of 20 ml. Buffer and enzyme were predispensed and the
reaction was started by the addition of substrate. Kinetic data were collected
at intervals of 2.5 or 3 min. First measurement was taken a few minutes after
the start of the reaction. From the obtained polarization values (P) the amount
of processed substrate (Pt) was calculated according to the following equation
(Levine et al., 1997): S = S0 – S0 $ ((Pt  Pmin)/(Pmax  Pmin)), where Pt is the
polarization measured (in mP); Pmax is the polarization of 100% unprocessed
substrate (determined for every reagent at all used substrate concentrations);
Pmin is the polarization of 100% processed substrate (determined for every
linkage at all used substrate concentrations by measuring the mP value for
the corresponding deubiquitinated TAMRA-peptide, which were synthesized
by SPPS according to the procedure described above); and S0 is the amount
of substrate added to the reaction. From the obtained Pt values the values for
initial velocities were calculated, and these values were used to determine the
Michaelis-Menten constants. These were linear for at least 30 min and cor-
rected for background signal (no enzyme). All experimental data was pro-
cessed using MS Excel and Prism 4.03 (GraphPad Software).SUPPLEMENTAL INFORMATION
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found with this article online at doi:10.1016/j.chembiol.2011.10.017.1, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1559
Chemistry & Biology
Biochemical Characterization of 12 USPsACKNOWLEDGMENTS
We thank Martin A. Cohn and Alan D’Andrea for USP1, USP12, USP46, and
UAF1 ccDNA, Annette Dirac and Rene Bernards for USP4 and USP8 cDNA,
Elisabetta Citterio for USP21 and USP39 cDNA, Carlos Lopex-Otin for
USP30 cDNA, and Erik Meulmeester and Frauke Melchior for USP25 cDNA.
We thank Ovaa and Sixma group members for discussion, sharing reagents,
and critical reading of the manuscript. This work was supported by grants
from the Dutch Cancer Society, the Netherlands Organization for Scientific
Research (VIDI grant), and EU-Rubicon and NWO-CW ECHO 700.59.009,
KWF-2008-4014, and STW.
USP expression and purification were performed by M.P.A.L.V. with assis-
tance from W.J.v.D; enzyme assays were designed and analyzed by A.C.F.
and executed by M.P.A.L.V and A.C.F.; USP1, USP12, USP46, and UAF1
were expressed, purified, and analyzed by M.C.; UbAMC was designed and
synthesized by R.M.; di-Ubs were designed by F.E. and H.O. and synthesized
by D.S.H.; FP reagents were designed by F.E., P.P.G., and H.O. and synthe-
sized by P.P.G. and F.E.; FP reagent assays were performed by P.P.G.;
H.O. supervised all synthesis efforts and FP experiments; T.K.S. designed
and supervised the USP project; data analysis and manuscript writing were
by A.C.F. with M.P.A.L.V. and T.K.S.
Received: July 1, 2011
Revised: October 11, 2011
Accepted: October 31, 2011
Published: December 22, 2011
REFERENCES
Avvakumov, G.V., Walker, J.R., Xue, S., Finerty, P.J., Jr., Mackenzie, F.,
Newman, E.M., and Dhe-Paganon, S. (2006). Amino-terminal dimerization,
NRDP1-rhodanese interaction, and inhibited catalytic domain conformation
of the ubiquitin-specific protease 8 (USP8). J. Biol. Chem. 281, 38061–38070.
Borodovsky, A., Kessler, B.M., Casagrande, R., Overkleeft, H.S., Wilkinson,
K.D., and Ploegh, H.L. (2001). A novel active site-directed probe specific for
deubiquitylating enzymes reveals proteasome association of USP14. EMBO
J. 20, 5187–5196.
Bremm, A., Freund, S.M., and Komander, D. (2010). Lys11-linked ubiquitin
chains adopt compact conformations and are preferentially hydrolyzed by
the deubiquitinase Cezanne. Nat. Struct. Mol. Biol. 17, 939–947.
Chastagner, P., Israe¨l, A., and Brou, C. (2006). Itch/AIP4 mediates Deltex
degradation through the formation of K29-linked polyubiquitin chains. EMBO
Rep. 7, 1147–1153.
Chastagner, P., Israe¨l, A., and Brou, C. (2008). AIP4/Itch regulates Notch
receptor degradation in the absence of ligand. PLoS ONE 3, e2735.
Chau, V., Tobias, J.W., Bachmair, A., Marriott, D., Ecker, D.J., Gonda, D.K.,
and Varshavsky, A. (1989). A multiubiquitin chain is confined to specific lysine
in a targeted short-lived protein. Science 243, 1576–1583.
Chen, Z.J., and Sun, L.J. (2009). Nonproteolytic functions of ubiquitin in cell
signaling. Mol. Cell 33, 275–286.
Cohn, M.A., Kowal, P., Yang, K., Haas, W., Huang, T.T., Gygi, S.P., and
D’Andrea, A.D. (2007). A UAF1-containing multisubunit protein complex regu-
lates the Fanconi anemia pathway. Mol. Cell 28, 786–797.
Cohn, M.A., Kee, Y., Haas, W., Gygi, S.P., and D’Andrea, A.D. (2009). UAF1 is
a subunit of multiple deubiquitinating enzyme complexes. J. Biol. Chem. 284,
5343–5351.
Cook, W.J., Jeffrey, L.C., Kasperek, E., and Pickart, C.M. (1994). Structure of
tetraubiquitin shows how multiubiquitin chains can be formed. J. Mol. Biol.
236, 601–609.
Cooper, E.M., Cutcliffe, C., Kristiansen, T.Z., Pandey, A., Pickart, C.M., and
Cohen, R.E. (2009). K63-specific deubiquitination by two JAMM/MPN+
complexes: BRISC-associated Brcc36 and proteasomal Poh1. EMBO J. 28,
621–631.
Dang, L.C., Melandri, F.D., and Stein, R.L. (1998). Kinetic and mechanistic
studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin
by deubiquitinating enzymes. Biochemistry 37, 1868–1879.1560 Chemistry & Biology 18, 1550–1561, December 23, 2011 ª2011Edelmann, M.J., Ipho¨fer, A., Akutsu, M., Altun, M., di Gleria, K., Kramer, H.B.,
Fiebiger, E., Dhe-Paganon, S., and Kessler, B.M. (2009). Structural basis and
specificity of human otubain 1-mediated deubiquitination. Biochem. J. 418,
379–390.
El Oualid, F., Merkx, R., Ekkebus, R., Hameed, D.S., Smit, J.J., de Jong, A.,
Hilkmann, H., Sixma, T.K., and Ovaa, H. (2010). Chemical synthesis of ubiqui-
tin, ubiquitin-based probes, and diubiquitin. Angew. Chem. Int. Ed. Engl. 49,
10149–10153.
Faesen, A.C., Dirac, A.M., Shanmugham, A., Ovaa, H., Perrakis, A., and Sixma,
T.K. (2011). Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-
like domain and allosteric regulation by GMP-synthetase. Mol. Cell 44,
147–159.
Ferna´ndez-Montalva´n, A., Bouwmeester, T., Joberty, G., Mader, R., Mahnke,
M., Pierrat, B., Schlaeppi, J.M., Worpenberg, S., and Gerhartz, B. (2007).
Biochemical characterization of USP7 reveals post-translational modification
sites and structural requirements for substrate processing and subcellular
localization. FEBS J. 274, 4256–4270.
Fitzgerald, D.J., Berger, P., Schaffitzel, C., Yamada, K., Richmond, T.J., and
Berger, I. (2006). Protein complex expression by using multigene baculoviral
vectors. Nat. Methods 3, 1021–1032.
Gerlach, B., Cordier, S.M., Schmukle, A.C., Emmerich, C.H., Rieser, E., Haas,
T.L., Webb, A.I., Rickard, J.A., Anderton, H., Wong, W.W., et al. (2011). Linear
ubiquitination prevents inflammation and regulates immune signalling. Nature
471, 591–596.
Hochstrasser, M. (2009). Origin and function of ubiquitin-like proteins. Nature
458, 422–429.
Hu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J.W., Gu, W., Cohen, R.E., and Shi, Y.
(2002). Crystal structure of a UBP-family deubiquitinating enzyme in isolation
and in complex with ubiquitin aldehyde. Cell 111, 1041–1054.
Hu, M., Li, P., Song, L., Jeffrey, P.D., Chenova, T.A., Wilkinson, K.D., Cohen,
R.E., and Shi, Y. (2005). Structure and mechanisms of the proteasome-asso-
ciated deubiquitinating enzyme USP14. EMBO J. 24, 3747–3756.
Jin, L., Williamson, A., Banerjee, S., Philipp, I., and Rape, M. (2008).
Mechanism of ubiquitin-chain formation by the human anaphase-promoting
complex. Cell 133, 653–665.
Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O’Rourke, K.M.,
Eby, M., Pietras, E., Cheng, G., Bazan, J.F., et al. (2007). DUBA: a deubiquiti-
nase that regulates type I interferon production. Science 318, 1628–1632.
Kee, Y., Yang, K., Cohn,M.A., Haas,W., Gygi, S.P., and D’Andrea, A.D. (2010).
WDR20 regulates activity of the USP12 x UAF1 deubiquitinating enzyme
complex. J. Biol. Chem. 285, 11252–11257.
Ko¨hler, A., Zimmerman, E., Schneider, M., Hurt, E., and Zheng, N. (2010).
Structural basis for assembly and activation of the heterotetrameric SAGA
histone H2B deubiquitinase module. Cell 141, 606–617.
Komander, D. (2010). Mechanism, specificity and structure of the deubiquiti-
nases. Subcell. Biochem. 54, 69–87.
Komander, D., Lord, C.J., Scheel, H., Swift, S., Hofmann, K., Ashworth, A., and
Barford, D. (2008). The structure of the CYLD USP domain explains its speci-
ficity for Lys63-linked polyubiquitin and reveals a B box module. Mol. Cell 29,
451–464.
Komander, D., Clague, M.J., and Urbe, S. (2009a). Breaking the chains: struc-
ture and function of the deubiquitinases. Nat. Rev. 10, 550–563.
Komander, D., Reyes-Turcu, F., Licchesi, J.D., Odenwaelder, P., Wilkinson,
K.D., and Barford, D. (2009b). Molecular discrimination of structurally equiva-
lent Lys 63-linked and linear polyubiquitin chains. EMBO Rep. 10, 466–473.
Levine, L.M., Michener, M.L., Toth, M.V., and Holwerda, B.C. (1997).
Measurement of specific protease activity utilizing fluorescence polarization.
Anal. Biochem. 247, 83–88.
Luna-Vargas, M.P., Christodoulou, E., Alfieri, A., van Dijk, P., Stadnik, M.,
Hibbert, R.G., Sahtoe, D.D., Clerici, M., Marco, V.D., Littler, D., et al.
(2011a). Enabling high-throughput ligation-independent cloning and protein
expression for the family of ubiquitin specific proteases. J. Struct. Biol. 175,
113–119.Elsevier Ltd All rights reserved
Chemistry & Biology
Biochemical Characterization of 12 USPsLuna-Vargas,M.P., Faesen, A.C., van Dijk,W.J., Rape,M., Fish, A., and Sixma,
T.K. (2011b). Ubiquitin-specific protease 4 is inhibited by its ubiquitin-like
domain. EMBO Rep. 12, 365–372.
Ma, J., Martin, J.D., Xue, Y., Lor, L.A., Kennedy-Wilson, K.M., Sinnamon, R.H.,
Ho, T.F., Zhang, G., Schwartz, B., Tummino, P.J., and Lai, Z. (2010). C-terminal
region of USP7/HAUSP is critical for deubiquitination activity and contains
a second mdm2/p53 binding site. Arch. Biochem. Biophys. 503, 207–212.
Matsumoto, M.L., Wickliffe, K.E., Dong, K.C., Yu, C., Bosanac, I., Bustos, D.,
Phu, L., Kirkpatrick, D.S., Hymowitz, S.G., Rape, M., et al. (2010). K11-linked
polyubiquitination in cell cycle control revealed by a K11 linkage-specific anti-
body. Mol. Cell 39, 477–484.
McCullough, J., Clague, M.J., and Urbe´, S. (2004). AMSH is an endosome-
associated ubiquitin isopeptidase. J. Cell Biol. 166, 487–492.
Meulmeester, E., Kunze, M., Hsiao, H.H., Urlaub, H., and Melchior, F. (2008).
Mechanism and consequences for paralog-specific sumoylation of ubiquitin-
specific protease 25. Mol. Cell 30, 610–619.
Nijman, S.M., Luna-Vargas, M.P., Velds, A., Brummelkamp, T.R., Dirac, A.M.,
Sixma, T.K., and Bernards, R. (2005). A genomic and functional inventory of
deubiquitinating enzymes. Cell 123, 773–786.
Pai, M.T., Tzeng, S.R., Kovacs, J.J., Keaton, M.A., Li, S.S., Yao, T.P., and
Zhou, P. (2007). Solution structure of the Ubp-M BUZ domain, a highly specific
protein module that recognizes the C-terminal tail of free ubiquitin. J. Mol. Biol.
370, 290–302.
Pickart, C.M. (2004). Back to the future with ubiquitin. Cell 116, 181–190.
Reyes-Turcu, F.E., Shanks, J.R., Komander, D., and Wilkinson, K.D. (2008).
Recognition of polyubiquitin isoforms by the multiple ubiquitin binding
modules of isopeptidase T. J. Biol. Chem. 283, 19581–19592.
Samara, N.L., Datta, A.B., Berndsen, C.E., Zhang, X., Yao, T., Cohen, R.E., and
Wolberger, C. (2010). Structural insights into the assembly and function of the
SAGA deubiquitinating module. Science 328, 1025–1029.
Sarkari, F., Sanchez-Alcaraz, T., Wang, S., Holowaty, M.N., Sheng, Y., and
Frappier, L. (2009). EBNA1-mediated recruitment of a histone H2B deubiquity-
lating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS
Pathog. 5, e1000624.
Shanmugham, A., Fish, A., Luna-Vargas, M.P., Faesen, A.C., El Oualid, F.,
Sixma, T.K., and Ovaa, H. (2010). Nonhydrolyzable ubiquitin-isopeptide iso-
steres as deubiquitinating enzyme probes. J. Am. Chem. Soc. 132, 8834–
8835.
Song, E.J., Werner, S.L., Neubauer, J., Stegmeier, F., Aspden, J., Rio, D.,
Harper, J.W., Elledge, S.J., Kirschner, M.W., and Rape, M. (2010). The
Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible
ubiquitination at the spliceosome. Genes Dev. 24, 1434–1447.
Sowa, M.E., Bennett, E.J., Gygi, S.P., and Harper, J.W. (2009). Defining the
human deubiquitinating enzyme interaction landscape. Cell 138, 389–403.
Tenno, T., Fujiwara, K., Tochio, H., Iwai, K., Morita, E.H., Hayashi, H., Murata,
S., Hiroaki, H., Sato, M., Tanaka, K., and Shirakawa,M. (2004). Structural basisChemistry & Biology 18, 1550–156for distinct roles of Lys63- and Lys48-linked polyubiquitin chains. Genes Cells
9, 865–875.
Thrower, J.S., Hoffman, L., Rechsteiner, M., and Pickart, C.M. (2000).
Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94–102.
Tirat, A., Schilb, A., Riou, V., Leder, L., Gerhartz, B., Zimmermann, J.,
Worpenberg, S., Eidhoff, U., Freuler, F., Stettler, T., et al. (2005). Synthesis
and characterization of fluorescent ubiquitin derivatives as highly sensitive
substrates for the deubiquitinating enzymes UCH-L3 and USP-2. Anal.
Biochem. 343, 244–255.
Tokunaga, F., Sakata, S., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K.,
Nakagawa, T., Kato, M., Murata, S., Yamaoka, S., et al. (2009). Involvement
of linear polyubiquitylation of NEMO in NF-kappaB activation. Nat. Cell Biol.
11, 123–132.
van der Knaap, J.A., Kumar, B.R., Moshkin, Y.M., Langenberg, K., Krijgsveld,
J., Heck, A.J., Karch, F., and Verrijzer, C.P. (2005). GMP synthetase stimulates
histone H2B deubiquitylation by the epigenetic silencer USP7. Mol. Cell 17,
695–707.
Varadan, R., Walker, O., Pickart, C., and Fushman, D. (2002). Structural prop-
erties of polyubiquitin chains in solution. J. Mol. Biol. 324, 637–647.
Virdee, S., Ye, Y., Nguyen, D.P., Komander, D., and Chin, J.W. (2010).
Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an
OTU deubiquitinase. Nat. Chem. Biol. 6, 750–757.
Wang, T., Yin, L., Cooper, E.M., Lai, M.Y., Dickey, S., Pickart, C.M., Fushman,
D.,Wilkinson, K.D., Cohen, R.E., andWolberger, C. (2009). Evidence for biden-
tate substrate binding as the basis for the K48 linkage specificity of otubain 1.
J. Mol. Biol. 386, 1011–1023.
Williamson, A., Wickliffe, K.E., Mellone, B.G., Song, L., Karpen, G.H., and
Rape, M. (2009). Identification of a physiological E2 module for the human
anaphase-promoting complex. Proc. Natl. Acad. Sci. USA 106, 18213–18218.
Wu, T., Merbl, Y., Huo, Y., Gallop, J.L., Tzur, A., and Kirschner, M.W. (2010).
UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-
promoting complex. Proc. Natl. Acad. Sci. USA 107, 1355–1360.
Wu-Baer, F., Lagrazon, K., Yuan, W., and Baer, R. (2003). The BRCA1/BARD1
heterodimer assembles polyubiquitin chains through an unconventional
linkage involving lysine residue K6 of ubiquitin. J. Biol. Chem. 278, 34743–
34746.
Ye, Y., Scheel, H., Hofmann, K., and Komander, D. (2009). Dissection of USP
catalytic domains reveals five common insertion points. Mol. Biosyst. 5, 1797–
1808.
Ye, Y., Akutsu, M., Reyes-Turcu, F., Enchev, R.I., Wilkinson, K.D., and
Komander, D. (2011). Polyubiquitin binding and cross-reactivity in the USP
domain deubiquitinase USP21. EMBO Rep. 12, 350–357.
Zhu, X., Me´nard, R., and Sulea, T. (2007). High incidence of ubiquitin-like
domains in human ubiquitin-specific proteases. Proteins 69, 1–7.1, December 23, 2011 ª2011 Elsevier Ltd All rights reserved 1561
